![Dominik Höchli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 20 506 $ in data 31/07/2026
Dominik Höchli is currently an Independent Non-Executive Director at Molecular Partners AG since 2021 and an Independent Director at Abivax SA starting in 2025.
Formerly, Dr. Höchli was Co-Managing Director at Catapult Therapeutics BV from 2021 to 2025 and Vice President & Head-Global Medical Affairs at AbbVie AG.
Education includes a doctorate from the University of Bern.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/12/2025 | 4.982 ( 0,01% ) | 20 506 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MOLECULAR PARTNERS AG | Direttore/Membro del Consiglio | 21/04/2021 |
| ABIVAX | Direttore/Membro del Consiglio | 22/04/2025 |
| Società | Posizione | Fine |
|---|---|---|
Catapult Therapeutics BV
 Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company which develops cancer treatments | Amministratore Delegato | 22/04/2025 |
AbbVie AG
 AbbVie AG Miscellaneous Commercial ServicesCommercial Services Develops and markets therapies | Direttore Tecnico/Scientifico/R&S | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
University of Bern
 University of Bern Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Partners AG
 Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
AbbVie AG
AbbVie AG Miscellaneous Commercial ServicesCommercial Services Develops and markets therapies | Commercial Services |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
Catapult Therapeutics BV
Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company which develops cancer treatments | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
